The Problem
The limits of long-term pain management
Catabolic effect of steroids
Repeated corticosteroid injections progressively damage tendon and cartilage tissue, limiting the number of treatments possible.
Symptomatic-only approach
Conventional analgesics mask pain without addressing the underlying inflammatory and tissue microenvironment.
Peripheral sensitisation
Chronic inflammation maintains nerve sensitisation. Without modulation of the local environment, pain persists.
The HQC Solution
Modulate inflammation. Regenerate the tissue.

Multi-target action
Sustained release of PDGF, TGF-β and IGF-1 acts on multiple targets: pro-inflammatory mediators, connective regeneration and peripheral sensitisation.
Steroid-free, repeatable
No catabolic effect on tendon or cartilage. Repeatable cycles without accumulation of local adverse effects.
Built for the workflow
Single-entry ergonomic design co-developed with pain specialists. Ultrasound-guided injection into joints, trigger points and tendons.
Designed with anaesthetists specialising in pain medicine: monthly or quarterly injection cycles into shoulder, hip, knee, myofascial trigger points and peripheral tendons — without the tissue-damaging ceiling of corticosteroids.
Download the complete product brochure
All technical details — Vulnology and Specialty Line.
